US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adicet Bio, Inc.

0.5258

-0.0455-7.96%

Post-market: 0.54000.0142+2.70%19:21 EDT

Volume:361.32K

Turnover:201.49K

Market Cap:43.48M

PE:-0.39

High:0.6099

Open:0.5800

Low:0.5229

Close:0.5713

Loading ...

Overview Company News Filings

Adicet Bio Inc - Preliminary Phase 1 Clinical Data Expected in First Half of 2025

THOMSON REUTERS

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma

Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases

Adicet Bio Inc - Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25

THOMSON REUTERS

Adicet Bio Inc - Preliminary Clinical Data in Lupus Nephritis Expected in 1H25

THOMSON REUTERS

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of Adi-001 in Autoimmune Diseases

THOMSON REUTERS

Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases

Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans?

Simply Wall St.

Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024

H.C. Wainwright Sticks to Its Hold Rating for Adicet Bio (ACET)

Adicet Bio Inc reports results for the quarter ended in September 30 - Earnings Summary

Adicet Bio Q3 EPS $(0.34) Beats $(0.35) Estimate

BRIEF-Adicet Bio Q3 Basic EPS USD -0.34

Adicet Bio : Expects That Current Cash, Cash Equivalents and Short-Term Investments Will Be Sufficient to Fund Its Operating Expenses Into H2 2026

THOMSON REUTERS

Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates

Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024

Adicet Bio Inc expected to post a loss of 34 cents a share - Earnings Preview

Adicet Bio to Participate in Upcoming Investor Conferences

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ACET/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACET","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","market":"US","secType":"STK","nameCN":"Adicet Bio, Inc.","latestPrice":0.5258,"timestamp":1744920000000,"preClose":0.5713,"halted":0,"volume":361320,"hourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5258,"latestTime":"19:21 EDT","volume":12938,"amount":7020.9282,"timestamp":1744932109696},"delay":0,"floatShares":61366114,"shares":82685750,"eps":-1.332954,"marketStatus":"Market Closed","change":-0.0455,"latestTime":"04-17 16:00:00 EDT","open":0.58,"high":0.6099,"low":0.5229,"amount":201487.56876,"amplitude":0.152284,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.332954,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1516942800000,"exchange":"NASDAQ","adjPreClose":0.5713,"preHourTrading":{"tag":"盘前","latestPrice":0.5713,"preClose":0.5713,"latestTime":"08:57 EDT","volume":387,"amount":224.0670015,"timestamp":1744894638946},"postHourTrading":{"tag":"盘后","latestPrice":0.54,"preClose":0.5258,"latestTime":"19:21 EDT","volume":12938,"amount":7020.9282,"timestamp":1744932109696},"volumeRatio":0.351103217185319,"impliedVol":2.2741,"impliedVolPercentile":0.9522},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ACET\",,,,,undefined,":{"symbol":"ACET","floatShares":61366114,"roa":"-37.31%","roe":"-65.65%","lyrEps":-1.332954,"volumeRatio":0.351103217185319,"shares":82685750,"dividePrice":0.04,"high":0.6099,"amplitude":0.152284,"preClose":0.5713,"low":0.5229,"week52Low":0.4471,"pbRate":"0.23","week52High":2.29,"institutionHeld":0.7488,"latestPrice":0.5258,"eps":-1.332954,"divideRate":0.076075,"volume":361320,"delay":0,"ttmEps":-1.332954,"open":0.58,"prevYearClose":0.962,"prevWeekClose":0.537,"prevMonthClose":0.755,"prevQuarterClose":0.755,"fiveDayClose":0.4471,"twentyDayClose":0.7643,"sixtyDayClose":0.918},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACET\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2484298679","title":"Adicet Bio Inc - Preliminary Phase 1 Clinical Data Expected in First Half of 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2484298679","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484298679?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:00","pubTimestamp":1731963600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUA6STTZW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2484398189","title":"Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2484398189","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484398189?lang=en_us&edition=fundamental","pubTime":"2024-11-19 05:00","pubTimestamp":1731963600,"startTime":"0","endTime":"0","summary":"First gamma delta CAR T cell therapy with the potential to address solid tumors entering clinical trials. Preliminary Phase 1 clinical data expected in the first half of 2025. \"Solid tumors represent one of the highest unmet medical needs in oncology and have yet to benefit from the breakthroughs observed with CAR T cell therapies in hematologic malignancies. Emerging data from ADI-270, our armored allogeneic 'off the shelf' gamma delta 1 CAR T cell therapy targeting CD70 positive cancers, have shown potential in addressing this gap,\" said Chen Schor, President and Chief Executive Officer. \"At the recent ASGCT conference, we presented preclinical data in which ADI-270 demonstrated significant tumor infiltration, resistance to the immunosuppressive tumor microenvironment, and potent activity via CAR and innate-mediated targeting, highlighting its potential for treating solid tumors. We look forward to enrolling patients and anticipate sharing preliminary clinical data from the trial in ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/JJqigpFV6jorjUuLk9sDkg--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/208047b7b25dbe57005c422a65638452","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/JJqigpFV6jorjUuLk9sDkg--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/208047b7b25dbe57005c422a65638452"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-opens-enrollment-adi-270-210000535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAR","BK4141","IE0031619046.USD","LU0957808578.USD","LU1244550494.USD","LU1992135472.HKD","RCC","BK4515","BK4139","LU1642822529.SGD","LU2237443549.SGD","LU1670710661.SGD","LU1861214812.USD","LU2237438978.USD","IE00B5949003.HKD","LU2298322129.HKD","IE0009356076.USD","LU2458330169.SGD","LU2360107325.USD","ADI","IE00BZ199S13.USD","LU2237443622.USD","LU0314104364.USD","LU1992135399.USD","BK4585","LU2272731782.SGD","LU1670711040.USD","LU0444971666.USD","LU1244550577.SGD","LU1861219969.SGD","LU0724618433.USD","LU2237443978.SGD","BK4588","LU0082616367.USD","LU0719512351.SGD","LU2237443382.USD","BK4230","IE00BD6J9T35.USD","BK4561","LU1074936037.SGD","LU1670711123.USD","BK4512","IE00B7SZL793.SGD","AEIS","BK4022","LU0889565833.HKD","LU1244550221.USD","LU0109392836.USD","LU2458330243.SGD","ACET"],"gpt_icon":0},{"id":"2484629153","title":"Adicet Bio:1st patient dosed in trial evaluating ADI-001 in autoimmune diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629153?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:15","pubTimestamp":1731932148,"startTime":"0","endTime":"0","summary":"Adicet Bio (ACET) announced that the first LN patient has been dosed in the Phase 1 clinical trial evaluating ADI-001 in autoimmune diseases. “Dosi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adicet-bio1st-patient-dosed-in-trial-evaluating-adi-001-in-autoimmune-diseases?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adicet-bio1st-patient-dosed-in-trial-evaluating-adi-001-in-autoimmune-diseases?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1244550494.USD","BK4585","IE00B5949003.HKD","LU0124384867.USD","LU1670711040.USD","LU1670710661.SGD","LU1861219969.SGD","BK4515","LU0444971666.USD","LU0957808578.USD","LU1815336760.USD","LU2237443978.SGD","LU2272731600.USD","LU2298322129.HKD","LU1074936037.SGD","LU1978683503.SGD","BK4512","BK4561","LU0109392836.USD","LU0889565833.HKD","LU2360107325.USD","LU1803068979.SGD","BK4139","IE00BD6J9T35.USD","LU2237443622.USD","IE00BZ199S13.USD","LU1992135399.USD","LU2458330169.SGD","BK4588","LU0314104364.USD","LU1670710588.SGD","LU1670711123.USD","IE0009356076.USD","ACET","LU1244550577.SGD","LU1244550221.USD","LU0082616367.USD","LU1861214812.USD","LU2237438978.USD","LU1642822529.SGD","LU2458330243.SGD","ADI","LU2272731782.SGD","LU2237443549.SGD","LU0724618433.USD","LU1992135472.HKD","LU2237443382.USD","BK4141","LU0719512351.SGD"],"gpt_icon":0},{"id":"2484668626","title":"Adicet Bio Inc - Enrollment for Sle, Ssc, Iim, SPS Expected in 1Q25","url":"https://stock-news.laohu8.com/highlight/detail?id=2484668626","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484668626?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUABJ27K4:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACET","BK4139"],"gpt_icon":0},{"id":"2484626665","title":"Adicet Bio Inc - Preliminary Clinical Data in Lupus Nephritis Expected in 1H25","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484626665?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUABJ27K4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2484626656","title":"Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of Adi-001 in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2484626656","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484626656?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nTUABJ27K4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2484629123","title":"Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629123","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629123?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:00","pubTimestamp":1731931200,"startTime":"0","endTime":"0","summary":"Preliminary clinical data in LN anticipated in 1H25. Initiation of patient enrollment in systemic lupus erythematosus , systemic sclerosis , idiopathic inflammatory myopathy  and stiff person syndrome  expected in 1Q25; patient enrollment in anti-neutrophil cytoplasmic autoantibody  associated vasculitis  expected in 2H25. The Phase 1 study has four separate arms, enrolling LN and SLE patients into one arm, SSc patients into a second arm, IIM and SPS patients in a third arm and AAV patients into a fourth arm. Enrolled patients will receive a single dose of ADI-001. The dose-limiting toxicity window is 28 days with response and safety assessments conducted on Day 28 and during the follow up period on months 3, 6, 9, 12, 18 and 24. The primary objectives of the study are to evaluate the safety and tolerability of ADI-001. Secondary objectives include measuring cellular kinetics, pharmacod","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/XpX5aBn6VdM8LbAAE_bE3g--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a863b0d98611ba55695cfeb883a2aff1","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/XpX5aBn6VdM8LbAAE_bE3g--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/a863b0d98611ba55695cfeb883a2aff1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-announces-first-lupus-120000573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2458330169.SGD","BK4077","BK4139","IE00BZ199S13.USD","LU0109392836.USD","LU0444971666.USD","LU0724618433.USD","LU2237443978.SGD","LU2272731600.USD","BK4515","LU2298322129.HKD","LU1244550221.USD","LU0082616367.USD","BK4561","LU1670711040.USD","LU1815336760.USD","LU2237443549.SGD","LU1861219969.SGD","BK4588","IIM","LU2237443622.USD","LU2272731782.SGD","LU1803068979.SGD","IE0009356076.USD","BK4141","LU1992135472.HKD","ADI","LU1244550494.USD","ACET","LU1074936037.SGD","LU1642822529.SGD","LU2360107325.USD","LU0124384867.USD","BK4585","LU0889565833.HKD","BK4512","LU0957808578.USD","LU1992135399.USD","LU0314104364.USD","SLE","LU1978683503.SGD","LU2237443382.USD","IE00B5949003.HKD","LU1244550577.SGD","LU2237438978.USD","LU1670710588.SGD","LU1861214812.USD","LU2458330243.SGD","IE00BD6J9T35.USD","LU1670710661.SGD"],"gpt_icon":0},{"id":"2484629122","title":"Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2484629122","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484629122?lang=en_us&edition=fundamental","pubTime":"2024-11-18 19:33","pubTimestamp":1731929632,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt.So should Adicet Bio  shareholders be worried about its cash burn?For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.When Might Adicet Bio Run Out Of Money?Even though its cash burn relative to its market cap makes us a little nervous, we are compelled to mention that we thought Adicet Bio's cash runway was relat","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-nasdaq-acet-good-113352881.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","TQQQ","QID","IE00B64PRP62.GBP","NQmain","PSQ",".IXIC","SQQQ","BK4585","MNQmain","LU2210150020.SGD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","IE00B3QW5Z07.USD","ACET","BK4112","LU2095319765.USD","NDAQ","QLD","IE00BGHQF748.EUR"],"gpt_icon":1},{"id":"2483514693","title":"Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483514693","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483514693?lang=en_us&edition=fundamental","pubTime":"2024-11-16 22:00","pubTimestamp":1731765600,"startTime":"0","endTime":"0","summary":"-Data demonstrate characteristics essential for treatment of autoimmune diseases, including robust tissue homing and complete CD19+ B cell depletion in secondary lymphoid tissue. -Results highlight the potential benefits unique to gamma delta 1 CAR T cell therapy and ADI-001's potential as a best-in-class off-the-shelf cell therapy for autoimmune diseases. REDWOOD CITY, Calif. & BOSTON, November 16, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic, gamma delta T cell therapies for autoimmune diseases and cancer, today announced that clinical biomarker data from the ADI-001 Phase 1 GLEAN trial which demonstrates robust tissue homing, significant CAR T cell activation, and complete CD19+ B cell depletion in secondary lymphoid tissue will be featured in an oral session at ACR Convergence 2024 in Washington, D.C., November 14-19.Concurrent with ADI-001 tissue trafficking and activation, complete depl","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/Rye59Ues0jMwXKyZll4xfA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/699cc1b32c1c1113d633cc9434ab438e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/Rye59Ues0jMwXKyZll4xfA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/699cc1b32c1c1113d633cc9434ab438e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-presents-clinical-biomarker-140000237.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CAR","BK4022","BK4117","SLE","BK4107","BK4077","BK4230","BK4139","IIM","ACR","AFG","BK4110","ACET"],"gpt_icon":0},{"id":"2481974162","title":"H.C. Wainwright Sticks to Its Hold Rating for Adicet Bio (ACET)","url":"https://stock-news.laohu8.com/highlight/detail?id=2481974162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481974162?lang=en_us&edition=fundamental","pubTime":"2024-11-07 19:19","pubTimestamp":1730978385,"startTime":"0","endTime":"0","summary":"In a report released today, Edward White from H.C. Wainwright reiterated a Hold rating on Adicet Bio (ACET – Research Report). The company’s shares...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-adicet-bio-acet?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-its-hold-rating-for-adicet-bio-acet?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ACET"],"gpt_icon":0},{"id":"2481118279","title":"Adicet Bio Inc reports results for the quarter ended in September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2481118279","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481118279?lang=en_us&edition=fundamental","pubTime":"2024-11-07 12:07","pubTimestamp":1730952460,"startTime":"0","endTime":"0","summary":"Adicet Bio Inc reports results for the quarter ended in September 30 - Earnings Summary  Adicet Bio Inc ACET.OQ reported a quarterly adjusted loss of 34 cents per share for the quarter ended September","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL8N3ME04O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET"],"gpt_icon":0},{"id":"2481895784","title":"Adicet Bio Q3 EPS $(0.34) Beats $(0.35) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2481895784","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481895784?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:38","pubTimestamp":1730929130,"startTime":"0","endTime":"0","summary":"Adicet Bio (NASDAQ:ACET) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.35) by 2.86 percent. This is a 52.11 percent increase over losses of $(0.71) per share from the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41788936/adicet-bio-q3-eps-0-34-beats-0-35-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adicet Bio Q3 EPS $(0.34) Beats $(0.35) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET"],"gpt_icon":0},{"id":"2481562429","title":"BRIEF-Adicet Bio Q3 Basic EPS USD -0.34","url":"https://stock-news.laohu8.com/highlight/detail?id=2481562429","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481562429?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:00","pubTimestamp":1730926846,"startTime":"0","endTime":"0","summary":"BRIEF-Adicet Bio Q3 Basic EPS USD -0.34\n\n\nNov 06 (Reuters) - Adicet Bio Q3 net income USD -30.478 million.\n\nQ3 operating income USD -33.153 million\nQ3 operating expenses USD 33.153 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nPLX998411:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET"],"gpt_icon":0},{"id":"2481959814","title":"Adicet Bio : Expects That Current Cash, Cash Equivalents and Short-Term Investments Will Be Sufficient to Fund Its Operating Expenses Into H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2481959814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481959814?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:00","pubTimestamp":1730926801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nTUAC47S0Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2481954624","title":"Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2481954624","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481954624?lang=en_us&edition=fundamental","pubTime":"2024-11-07 05:00","pubTimestamp":1730926800,"startTime":"0","endTime":"0","summary":"ADI-001 Phase 1 clinical trial expanded to include a total of six autoimmune disease indications; preliminary clinical data in lupus nephritis  anticipated in 1H25. Strong balance sheet with $202.1 million in cash, cash equivalents and short-term investments as of September 30, 2024. REDWOOD CITY, Calif. & BOSTON, November 06, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today reported financial results and operational highlights for the third quarter ended September 30, 2024.FDA clearance of IND amendment to evaluate ADI-001 in IIM and SPS. In October 2024, Adicet announced that the U.S. Food and Drug Administration  cleared the Company’s Investigational New Drug  amendment application to evaluate ADI-001 in IIM and SPS as part of the Phase 1 clinical trial in autoimmune diseases.Presented ADI-001 clinical biomarker data demonstrating robust tissue trafficking an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-reports-third-quarter-2024-210000809.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4230","ACR","BK4139","IIM","BK4110","ACET","CAR","BK4077","BK4022","SLE"],"gpt_icon":0},{"id":"2481085775","title":"Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2481085775","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481085775?lang=en_us&edition=fundamental","pubTime":"2024-11-05 20:00","pubTimestamp":1730808000,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, November 05, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced acceptance of an oral presentation at the upcoming American College of Rheumatology  Convergence 2024 meeting, taking place November 14-19, 2024, in Washington, D.C.Title: ADI-001: An Allogeneic CD20-targeted γδ CAR T Cell Therapy with Potential for Improved Tissue Homing in Autoimmune IndicationsSession Name: Abstracts: Miscellaneous Rheumatic & Inflammatory Diseases IIAbstract Number: 1866169Presenting Author: Monica Moreno, Ph.D.Date and Time: November 19, 2024; 12:00 p.m. – 12:15 p.m. ET","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/E2BwQHr0trUKZ6AJmJh2mA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5eba4b981214073db274dba960d3dede","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/E2BwQHr0trUKZ6AJmJh2mA--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/5eba4b981214073db274dba960d3dede"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-present-american-college-120000102.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","AFG","ACR","BK4117","BK4110","BK4107","ACET"],"gpt_icon":0},{"id":"2481569590","title":"Adicet Bio Inc    expected to post a loss of 34 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481569590","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481569590?lang=en_us&edition=fundamental","pubTime":"2024-11-05 06:49","pubTimestamp":1730760559,"startTime":"0","endTime":"0","summary":"* Adicet Bio Inc     is expected to show no change in quarterly revenue when it reports  results on November 6 (estimated) for the period ending January 1 0001   *    * LSEG's mean analyst estimate fo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Adicet Bio Inc    expected to post a loss of 34 cents a share - Earnings Preview","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACET"],"gpt_icon":0},{"id":"2480000508","title":"Adicet Bio to Participate in Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2480000508","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480000508?lang=en_us&edition=fundamental","pubTime":"2024-11-01 19:00","pubTimestamp":1730458800,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, November 01, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that company management will participate in three upcoming investor conferences in November.Truist Securities BioPharma Symposium, November 7, 2024, New York, NY. Members of management will be available for 1x1 meetings on November 7, 2024. Guggenheim Securities Healthcare Innovation Conference, November 11-13, 2024, Boston, MA. Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on November 12, 2024 at 3:00 p.m. ET. Jefferies London Healthcare Conference, November 19-21, 2024, London. Chen Schor, President and Chief Executive Officer, will participate in a fireside chat on November 19, 2024 at 12:30 p.m. BST","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/7OtiIQ4a8JmoThr2zwwrQg--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9046d1f838740b79ffc69ce30c83defe","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/7OtiIQ4a8JmoThr2zwwrQg--~B/aD0yODg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/9046d1f838740b79ffc69ce30c83defe"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-participate-upcoming-investor-110000619.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ACET"],"gpt_icon":0},{"id":"2480098606","title":"Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2480098606","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480098606?lang=en_us&edition=fundamental","pubTime":"2024-11-01 05:31","pubTimestamp":1730410260,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif. & BOSTON, October 31, 2024----Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted inducement awards on October 31, 2024.All of the above-described awards were granted outside of Adicet’s stockholder-approved equity incentive plans pursuant to Adicet’s 2022 Inducement Plan , which was adopted by the board of directors in January 2022 and subsequently amended in January 2023. The awards were authorized by the compensation committee of the board of directors, which is comprised solely of independent directors, as a material inducement to the employees entering into employment with Adicet in accordance with Nasdaq Listing Rule 5635.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adicet-bio-reports-inducement-grants-213100235.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","ACET","IE00B64PRP62.GBP","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BKPKM429.USD",".IXIC","BK4139","LU2095319765.USD","BK4112","BK4585","LU2210149790.SGD","LU2210150020.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":59,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACET\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"ACET","fiscalQuarterEnding":"2024/12","expectedEps":-0.37,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-11-06","symbol":"ACET","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2024-08-13","symbol":"ACET","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.33},{"market":"US","date":"2024-05-14","symbol":"ACET","fiscalQuarterEnding":"2024/03","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2024-03-19","symbol":"ACET","fiscalQuarterEnding":"2023/12","expectedEps":-0.72,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1710820800000,"reportTimeType":"post","actualEps":-0.69}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACET\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ACET\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.375,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":8,"updateTime":1727755200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ACET\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ACET","date":"2025-04-17","current":-0.403326,"percent":0.977798,"low":-20.788688,"twenty":-11.153299,"median":-4.755552,"eighty":-0.78812,"high":-0.315643,"avg":-5.832501,"sd":5.145346,"marketCap":47238368},"quantilePoints":[{"date":"2020-09-18","current":-12.223294,"twenty":-11.014673,"median":-9.201742,"eighty":-8.958418,"marketCap":419222319},{"date":"2020-09-25","current":-6.328696,"twenty":-9.039526,"median":-7.068377,"eighty":-6.14706,"marketCap":217055294},{"date":"2020-10-02","current":-6.791354,"twenty":-8.357534,"median":-6.791354,"eighty":-6.153914,"marketCap":232923054},{"date":"2020-10-09","current":-7.836617,"twenty":-7.781783,"median":-6.965564,"eighty":-6.372106,"marketCap":268772440},{"date":"2020-10-16","current":-7.72238,"twenty":-7.822909,"median":-7.21974,"eighty":-6.578874,"marketCap":264854474},{"date":"2020-10-23","current":-7.134063,"twenty":-7.77036,"median":-7.288282,"eighty":-6.791354,"marketCap":244676951},{"date":"2020-10-30","current":-6.123071,"twenty":-7.720095,"median":-7.15691,"eighty":-6.52861,"marketCap":210002956},{"date":"2020-11-06","current":-6.806308,"twenty":-7.709814,"median":-6.991267,"eighty":-6.430367,"marketCap":233442752},{"date":"2020-11-13","current":-7.600663,"twenty":-7.669831,"median":-6.996979,"eighty":-6.430367,"marketCap":260687541},{"date":"2020-11-20","current":-7.314924,"twenty":-7.615433,"median":-7.074903,"eighty":-6.437221,"marketCap":250887257},{"date":"2020-11-27","current":-7.103477,"twenty":-7.598377,"median":-7.117764,"eighty":-6.482916,"marketCap":243635047},{"date":"2020-12-04","current":-7.863543,"twenty":-7.620356,"median":-7.103477,"eighty":-6.690826,"marketCap":269703801},{"date":"2020-12-11","current":-7.177769,"twenty":-7.620356,"median":-7.145487,"eighty":-6.791354,"marketCap":246183121},{"date":"2020-12-18","current":-8.275008,"twenty":-7.647524,"median":-7.177769,"eighty":-6.794345,"marketCap":283816210},{"date":"2020-12-24","current":-8.200715,"twenty":-7.72238,"median":-7.206343,"eighty":-6.806308,"marketCap":281268136},{"date":"2020-12-31","current":-8.029272,"twenty":-7.842002,"median":-7.231164,"eighty":-6.81088,"marketCap":275387966},{"date":"2021-01-08","current":-7.840684,"twenty":-7.880687,"median":-7.274921,"eighty":-6.83031,"marketCap":268919779},{"date":"2021-01-15","current":-7.486367,"twenty":-7.864686,"median":-7.354927,"eighty":-6.841184,"marketCap":256767427},{"date":"2021-01-22","current":-8.309296,"twenty":-7.958409,"median":-7.448213,"eighty":-6.851749,"marketCap":284992244},{"date":"2021-01-29","current":-7.029185,"twenty":-7.965266,"median":-7.450146,"eighty":-6.865888,"marketCap":241086974},{"date":"2021-02-05","current":-7.240632,"twenty":-7.953837,"median":-7.354927,"eighty":-6.880317,"marketCap":248339183},{"date":"2021-02-12","current":-14.744768,"twenty":-7.988752,"median":-7.450146,"eighty":-6.910317,"marketCap":505716040},{"date":"2021-02-19","current":-14.71987,"twenty":-8.032701,"median":-7.472996,"eighty":-6.929451,"marketCap":504862118},{"date":"2021-02-26","current":-13.980224,"twenty":-8.198429,"median":-7.528178,"eighty":-6.940161,"marketCap":479493736},{"date":"2021-03-05","current":-12.510064,"twenty":-8.300152,"median":-7.586376,"eighty":-6.958322,"marketCap":429070163},{"date":"2021-03-12","current":-12.789081,"twenty":-8.654016,"median":-7.625279,"eighty":-6.977444,"marketCap":469077921},{"date":"2021-03-19","current":-12.606418,"twenty":-12.160165,"median":-7.660668,"eighty":-6.990125,"marketCap":462378194},{"date":"2021-03-26","current":-11.392595,"twenty":-12.364733,"median":-7.699533,"eighty":-6.998432,"marketCap":417857597},{"date":"2021-04-01","current":-11.366584,"twenty":-12.191729,"median":-7.716668,"eighty":-7.00404,"marketCap":416903584},{"date":"2021-04-09","current":-11.435946,"twenty":-12.010661,"median":-7.732957,"eighty":-7.020041,"marketCap":419447618},{"date":"2021-04-16","current":-10.61228,"twenty":-11.720327,"median":-7.806395,"eighty":-7.032614,"marketCap":389237214},{"date":"2021-04-23","current":-12.302962,"twenty":-11.720327,"median":-7.83865,"eighty":-7.050901,"marketCap":451248044},{"date":"2021-04-30","current":-13.811571,"twenty":-12.427812,"median":-7.869258,"eighty":-7.07376,"marketCap":506580786},{"date":"2021-05-07","current":-12.346313,"twenty":-12.499856,"median":-7.966409,"eighty":-7.094333,"marketCap":452838066},{"date":"2021-05-14","current":-11.636081,"twenty":-12.436483,"median":-7.996548,"eighty":-7.109192,"marketCap":426788194},{"date":"2021-05-21","current":-8.596808,"twenty":-12.339377,"median":-8.0207,"eighty":-7.132453,"marketCap":460023817},{"date":"2021-05-28","current":-7.978504,"twenty":-12.309898,"median":-8.029272,"eighty":-7.138632,"marketCap":426937733},{"date":"2021-06-04","current":-7.294802,"twenty":-12.302962,"median":-7.996548,"eighty":-7.15691,"marketCap":390352160},{"date":"2021-06-11","current":-6.98565,"twenty":-12.223294,"median":-7.975314,"eighty":-7.132051,"marketCap":373809118},{"date":"2021-06-18","current":-6.266277,"twenty":-12.065471,"median":-7.949265,"eighty":-7.069188,"marketCap":335314732},{"date":"2021-06-25","current":-5.766877,"twenty":-11.817433,"median":-7.852113,"eighty":-7.000611,"marketCap":308591357},{"date":"2021-07-02","current":-5.903617,"twenty":-11.791422,"median":-7.835818,"eighty":-6.985555,"marketCap":315908472},{"date":"2021-07-09","current":-5.499341,"twenty":-11.667149,"median":-7.806395,"eighty":-6.932583,"marketCap":294275263},{"date":"2021-07-16","current":-4.637283,"twenty":-11.621631,"median":-7.77184,"eighty":-6.854786,"marketCap":248145627},{"date":"2021-07-23","current":-4.833475,"twenty":-11.479297,"median":-7.720674,"eighty":-6.81088,"marketCap":258644096},{"date":"2021-07-30","current":-4.399473,"twenty":-11.43768,"median":-7.704389,"eighty":-6.63694,"marketCap":235420210},{"date":"2021-08-06","current":-4.155719,"twenty":-11.435946,"median":-7.66924,"eighty":-6.406377,"marketCap":222376658},{"date":"2021-08-13","current":-4.402445,"twenty":-11.401265,"median":-7.627258,"eighty":-6.225849,"marketCap":246140692},{"date":"2021-08-20","current":-3.941128,"twenty":-11.371786,"median":-7.589233,"eighty":-6.116457,"marketCap":220348459},{"date":"2021-08-27","current":-4.596084,"twenty":-11.366584,"median":-7.547276,"eighty":-6.002308,"marketCap":256967062},{"date":"2021-09-03","current":-4.533436,"twenty":-11.345776,"median":-7.482484,"eighty":-5.806364,"marketCap":253464413},{"date":"2021-09-10","current":-4.334102,"twenty":-11.309361,"median":-7.452079,"eighty":-5.73834,"marketCap":242319621},{"date":"2021-09-17","current":-4.0949,"twenty":-11.288553,"median":-7.415748,"eighty":-5.46367,"marketCap":228945870},{"date":"2021-09-24","current":-4.328406,"twenty":-11.283351,"median":-7.354927,"eighty":-5.029668,"marketCap":242001198},{"date":"2021-10-01","current":-4.630256,"twenty":-11.274681,"median":-7.307836,"eighty":-4.803749,"marketCap":258877598},{"date":"2021-10-08","current":-4.197415,"twenty":-11.250823,"median":-7.276966,"eighty":-4.755552,"marketCap":234677478},{"date":"2021-10-15","current":-4.578998,"twenty":-11.231609,"median":-7.234917,"eighty":-4.643318,"marketCap":256011794},{"date":"2021-10-22","current":-4.61317,"twenty":-11.191447,"median":-7.21974,"eighty":-4.634472,"marketCap":257922330},{"date":"2021-10-29","current":-4.897933,"twenty":-11.161969,"median":-7.180626,"eighty":-4.634472,"marketCap":273843461},{"date":"2021-11-05","current":-5.23965,"twenty":-11.142894,"median":-7.166339,"eighty":-4.643318,"marketCap":292948819},{"date":"2021-11-12","current":-5.650037,"twenty":-11.101277,"median":-7.134172,"eighty":-4.661011,"marketCap":311565637},{"date":"2021-11-19","current":-5.395061,"twenty":-11.075267,"median":-7.103477,"eighty":-4.700877,"marketCap":297505239},{"date":"2021-11-26","current":-5.447215,"twenty":-11.050991,"median":-7.080774,"eighty":-4.730547,"marketCap":300381230},{"date":"2021-12-03","current":-5.679011,"twenty":-11.002438,"median":-7.037757,"eighty":-4.748799,"marketCap":313163410},{"date":"2021-12-10","current":-9.859615,"twenty":-10.830768,"median":-7.080774,"eighty":-4.755552,"marketCap":543698631},{"date":"2021-12-17","current":-11.250893,"twenty":-10.84203,"median":-7.117764,"eighty":-4.75783,"marketCap":620419244},{"date":"2021-12-23","current":-11.300581,"twenty":-11.061395,"median":-7.134172,"eighty":-4.762613,"marketCap":623159266},{"date":"2021-12-31","current":-12.415023,"twenty":-11.108913,"median":-7.166339,"eighty":-4.768078,"marketCap":684614043},{"date":"2022-01-07","current":-11.016647,"twenty":-11.165437,"median":-7.180626,"eighty":-4.774685,"marketCap":607501998},{"date":"2022-01-14","current":-10.335205,"twenty":-11.153299,"median":-7.21974,"eighty":-4.806397,"marketCap":569924555},{"date":"2022-01-21","current":-8.468338,"twenty":-11.13249,"median":-7.234917,"eighty":-4.82753,"marketCap":466978018},{"date":"2022-01-28","current":-8.297977,"twenty":-11.116024,"median":-7.258799,"eighty":-4.833475,"marketCap":457583657},{"date":"2022-02-04","current":-8.951026,"twenty":-11.080469,"median":-7.300747,"eighty":-4.869457,"marketCap":493595373},{"date":"2022-02-11","current":-11.094729,"twenty":-11.080469,"median":-7.350163,"eighty":-4.875092,"marketCap":611807747},{"date":"2022-02-18","current":-9.66796,"twenty":-11.071799,"median":-7.413707,"eighty":-4.897933,"marketCap":533129975},{"date":"2022-02-25","current":-9.75314,"twenty":-11.030182,"median":-7.448213,"eighty":-4.938939,"marketCap":537827155},{"date":"2022-03-04","current":-8.915534,"twenty":-11.017273,"median":-7.472996,"eighty":-4.958303,"marketCap":491638215},{"date":"2022-03-11","current":-9.305944,"twenty":-11.010969,"median":-7.528178,"eighty":-4.97425,"marketCap":513166958},{"date":"2022-03-18","current":-10.355352,"twenty":-11.009549,"median":-7.586376,"eighty":-4.990731,"marketCap":642021454},{"date":"2022-03-25","current":-11.06286,"twenty":-11.009549,"median":-7.625279,"eighty":-5.041559,"marketCap":685886274},{"date":"2022-04-01","current":-13.384775,"twenty":-11.028394,"median":-7.660668,"eighty":-5.170516,"marketCap":829842638},{"date":"2022-04-08","current":-11.731777,"twenty":-11.098988,"median":-7.699533,"eighty":-5.231677,"marketCap":727358468},{"date":"2022-04-14","current":-10.876335,"twenty":-11.12261,"median":-7.716668,"eighty":-5.249902,"marketCap":674321913},{"date":"2022-04-22","current":-8.988146,"twenty":-11.103247,"median":-7.732957,"eighty":-5.26357,"marketCap":557256054},{"date":"2022-04-29","current":-9.510787,"twenty":-11.086173,"median":-7.802346,"eighty":-5.278378,"marketCap":589659313},{"date":"2022-05-06","current":-9.678549,"twenty":-11.077622,"median":-7.829679,"eighty":-5.295464,"marketCap":600060360},{"date":"2022-05-13","current":-13.123275,"twenty":-11.086173,"median":-7.836617,"eighty":-5.305715,"marketCap":473251543},{"date":"2022-05-20","current":-11.769903,"twenty":-11.161969,"median":-7.861263,"eighty":-5.31851,"marketCap":424446227},{"date":"2022-05-27","current":-13.034529,"twenty":-11.242695,"median":-7.869258,"eighty":-5.340635,"marketCap":470051194},{"date":"2022-06-03","current":-12.757199,"twenty":-11.285085,"median":-7.960694,"eighty":-5.368451,"marketCap":460050105},{"date":"2022-06-10","current":-13.234207,"twenty":-11.327253,"median":-7.981029,"eighty":-5.399697,"marketCap":477251979},{"date":"2022-06-17","current":-13.00125,"twenty":-11.375618,"median":-8.012128,"eighty":-5.411287,"marketCap":468851064},{"date":"2022-06-24","current":-15.120054,"twenty":-11.422222,"median":-8.034987,"eighty":-5.419003,"marketCap":545259385},{"date":"2022-07-01","current":-16.284842,"twenty":-11.553978,"median":-8.091112,"eighty":-5.423608,"marketCap":587263960},{"date":"2022-07-08","current":-20.633383,"twenty":-11.719384,"median":-8.168751,"eighty":-5.42983,"marketCap":744081040},{"date":"2022-07-15","current":-20.178561,"twenty":-11.769903,"median":-8.184404,"eighty":-5.44142,"marketCap":727679253},{"date":"2022-07-22","current":-18.913934,"twenty":-11.969581,"median":-8.226432,"eighty":-5.44142,"marketCap":682074286},{"date":"2022-07-29","current":-18.736442,"twenty":-12.060106,"median":-8.275008,"eighty":-5.447215,"marketCap":675673589},{"date":"2022-08-05","current":-20.788688,"twenty":-12.223294,"median":-8.303636,"eighty":-5.46367,"marketCap":749681650},{"date":"2022-08-12","current":-13.750684,"twenty":-12.362103,"median":-8.343585,"eighty":-5.46367,"marketCap":656540161},{"date":"2022-08-19","current":-12.768492,"twenty":-12.509551,"median":-8.420735,"eighty":-5.499341,"marketCap":609644435},{"date":"2022-08-26","current":-12.813137,"twenty":-12.536338,"median":-8.482534,"eighty":-5.510959,"marketCap":611776059},{"date":"2022-09-02","current":-12.777421,"twenty":-12.592247,"median":-8.603556,"eighty":-5.516754,"marketCap":610070760},{"date":"2022-09-09","current":-14.634657,"twenty":-12.609234,"median":-8.645174,"eighty":-5.544569,"marketCap":698746314},{"date":"2022-09-16","current":-14.072129,"twenty":-12.704679,"median":-8.738075,"eighty":-5.600145,"marketCap":671887853},{"date":"2022-09-23","current":-12.411332,"twenty":-12.737344,"median":-8.830852,"eighty":-5.64249,"marketCap":592591444},{"date":"2022-09-30","current":-12.69706,"twenty":-12.737344,"median":-8.887141,"eighty":-5.673216,"marketCap":606233837},{"date":"2022-10-07","current":-13.304233,"twenty":-12.761349,"median":-8.922632,"eighty":-5.692229,"marketCap":635223922},{"date":"2022-10-14","current":-14.831095,"twenty":-12.793892,"median":-8.951026,"eighty":-5.705496,"marketCap":708125459},{"date":"2022-10-21","current":-15.473984,"twenty":-12.959137,"median":-8.99443,"eighty":-5.755099,"marketCap":738820843},{"date":"2022-10-28","current":-15.348978,"twenty":-13.011811,"median":-9.007813,"eighty":-5.766877,"marketCap":732852296},{"date":"2022-11-04","current":-15.956151,"twenty":-13.109866,"median":-9.211253,"eighty":-5.781146,"marketCap":761842381},{"date":"2022-11-11","current":-16.355298,"twenty":-13.154285,"median":-9.27755,"eighty":-5.806364,"marketCap":911448044},{"date":"2022-11-18","current":-13.51023,"twenty":-13.225939,"median":-9.316592,"eighty":-5.88173,"marketCap":752898078},{"date":"2022-11-25","current":-13.187276,"twenty":-13.261571,"median":-9.354812,"eighty":-5.901857,"marketCap":734900515},{"date":"2022-12-02","current":-14.809734,"twenty":-13.320734,"median":-9.452716,"eighty":-5.911914,"marketCap":825316846},{"date":"2022-12-09","current":-13.279548,"twenty":-13.423882,"median":-9.515167,"eighty":-5.934118,"marketCap":740042676},{"date":"2022-12-16","current":-7.228011,"twenty":-13.398989,"median":-9.452716,"eighty":-5.976733,"marketCap":402802614},{"date":"2022-12-23","current":-6.097673,"twenty":-13.354338,"median":-9.354812,"eighty":-6.009039,"marketCap":339811142},{"date":"2022-12-30","current":-6.8743,"twenty":-13.325172,"median":-9.316592,"eighty":-6.00527,"marketCap":383090997},{"date":"2023-01-06","current":-6.443695,"twenty":-13.310335,"median":-9.281099,"eighty":-6.018456,"marketCap":359094245},{"date":"2023-01-13","current":-6.682066,"twenty":-13.30391,"median":-9.220763,"eighty":-5.960806,"marketCap":372378161},{"date":"2023-01-20","current":-6.797406,"twenty":-13.302617,"median":-9.171075,"eighty":-5.997732,"marketCap":378805863},{"date":"2023-01-27","current":-6.889679,"twenty":-13.279548,"median":-9.004264,"eighty":-6.016577,"marketCap":383948024},{"date":"2023-02-03","current":-6.735891,"twenty":-13.234207,"median":-8.958124,"eighty":-6.02597,"marketCap":375377755},{"date":"2023-02-10","current":-6.236082,"twenty":-13.225723,"median":-8.933129,"eighty":-6.037393,"marketCap":347524383},{"date":"2023-02-17","current":-6.489831,"twenty":-13.223872,"median":-8.915534,"eighty":-6.037393,"marketCap":361665326},{"date":"2023-02-24","current":-5.89006,"twenty":-13.194595,"median":-8.860478,"eighty":-6.03412,"marketCap":328241279},{"date":"2023-03-03","current":-5.982333,"twenty":-13.171574,"median":-8.80263,"eighty":-6.012808,"marketCap":333383440},{"date":"2023-03-10","current":-5.490213,"twenty":-13.16286,"median":-8.723879,"eighty":-5.944964,"marketCap":305958581},{"date":"2023-03-17","current":-4.573083,"twenty":-13.154285,"median":-8.610305,"eighty":-5.932447,"marketCap":319155464},{"date":"2023-03-24","current":-3.62523,"twenty":-13.129108,"median":-8.483849,"eighty":-5.897386,"marketCap":253004802},{"date":"2023-03-31","current":-3.545216,"twenty":-13.118034,"median":-8.454537,"eighty":-5.866992,"marketCap":247420656},{"date":"2023-04-06","current":-3.37288,"twenty":-13.113999,"median":-8.398808,"eighty":-5.809257,"marketCap":235393263},{"date":"2023-04-14","current":-3.557526,"twenty":-13.110445,"median":-8.342168,"eighty":-5.748484,"marketCap":248279755},{"date":"2023-04-21","current":-3.723921,"twenty":-13.086876,"median":-8.297405,"eighty":-5.667421,"marketCap":259892457},{"date":"2023-04-28","current":-3.55773,"twenty":-13.049491,"median":-8.275008,"eighty":-5.514436,"marketCap":248293951},{"date":"2023-05-05","current":-3.927044,"twenty":-13.024915,"median":-8.226432,"eighty":-5.46367,"marketCap":274068409},{"date":"2023-05-12","current":-2.71725,"twenty":-13.015752,"median":-8.184404,"eighty":-5.436784,"marketCap":286096490},{"date":"2023-05-19","current":-2.63566,"twenty":-13.012337,"median":-8.176277,"eighty":-5.402015,"marketCap":277506005},{"date":"2023-05-26","current":-2.256223,"twenty":-13.01026,"median":-8.097409,"eighty":-5.305715,"marketCap":237555450},{"date":"2023-06-02","current":-2.119544,"twenty":-13.006246,"median":-8.052131,"eighty":-5.261292,"marketCap":223164659},{"date":"2023-06-09","current":-2.313342,"twenty":-12.997558,"median":-8.029272,"eighty":-5.082716,"marketCap":243569512},{"date":"2023-06-16","current":-1.848226,"twenty":-12.976876,"median":-8.004338,"eighty":-4.951469,"marketCap":194597864},{"date":"2023-06-23","current":-1.782946,"twenty":-12.959137,"median":-7.983554,"eighty":-4.873965,"marketCap":187724650},{"date":"2023-06-30","current":-0.942473,"twenty":-12.911961,"median":-7.972124,"eighty":-4.816964,"marketCap":99232023},{"date":"2023-07-07","current":-1.28111,"twenty":-12.868469,"median":-7.949265,"eighty":-4.763979,"marketCap":134886820},{"date":"2023-07-14","current":-1.31783,"twenty":-12.843199,"median":-7.863618,"eighty":-4.74542,"marketCap":138753002},{"date":"2023-07-21","current":-1.207671,"twenty":-12.830007,"median":-7.840684,"eighty":-4.656454,"marketCap":127154454},{"date":"2023-07-28","current":-1.019992,"twenty":-12.803515,"median":-7.829679,"eighty":-4.602918,"marketCap":107393965},{"date":"2023-08-04","current":-0.966953,"twenty":-12.784417,"median":-7.802346,"eighty":-4.569798,"marketCap":101809478},{"date":"2023-08-11","current":-0.878871,"twenty":-12.773849,"median":-7.732957,"eighty":-4.533436,"marketCap":101205471},{"date":"2023-08-18","current":-0.736755,"twenty":-12.768492,"median":-7.716668,"eighty":-4.477622,"marketCap":84840331},{"date":"2023-08-25","current":-0.654478,"twenty":-12.76492,"median":-7.684387,"eighty":-4.455547,"marketCap":75365776},{"date":"2023-09-01","current":-0.747975,"twenty":-12.758617,"median":-7.652096,"eighty":-4.400662,"marketCap":86132316},{"date":"2023-09-08","current":-0.665698,"twenty":-12.756521,"median":-7.629237,"eighty":-4.34242,"marketCap":76657761},{"date":"2023-09-15","current":-0.669438,"twenty":-12.75227,"median":-7.594948,"eighty":-4.312673,"marketCap":77088422},{"date":"2023-09-22","current":-0.572201,"twenty":-12.743915,"median":-7.566374,"eighty":-4.236574,"marketCap":65891221},{"date":"2023-09-29","current":-0.531062,"twenty":-12.727534,"median":-7.484426,"eighty":-4.198554,"marketCap":61153944},{"date":"2023-10-06","current":-0.493664,"twenty":-12.69706,"median":-7.452079,"eighty":-4.156908,"marketCap":56847328},{"date":"2023-10-13","current":-0.504883,"twenty":-12.691703,"median":-7.415748,"eighty":-4.13135,"marketCap":58139313},{"date":"2023-10-20","current":-0.546022,"twenty":-12.664916,"median":-7.354927,"eighty":-4.067563,"marketCap":62876590},{"date":"2023-10-27","current":-0.478704,"twenty":-12.654201,"median":-7.3454,"eighty":-4.043715,"marketCap":55124682},{"date":"2023-11-03","current":-0.553502,"twenty":-12.626447,"median":-7.297775,"eighty":-4.002637,"marketCap":63737913},{"date":"2023-11-10","current":-0.376337,"twenty":-12.610697,"median":-7.240632,"eighty":-3.935494,"marketCap":53832697},{"date":"2023-11-17","current":-0.353056,"twenty":-12.606959,"median":-7.23304,"eighty":-3.832918,"marketCap":50502490},{"date":"2023-11-24","current":-0.359091,"twenty":-12.604608,"median":-7.223876,"eighty":-3.775539,"marketCap":51365781},{"date":"2023-12-01","current":-0.356073,"twenty":-12.598035,"median":-7.183484,"eighty":-3.742387,"marketCap":50934135},{"date":"2023-12-08","current":-0.413407,"twenty":-12.591669,"median":-7.172054,"eighty":-3.680708,"marketCap":59135395},{"date":"2023-12-15","current":-0.497899,"twenty":-12.589369,"median":-7.134281,"eighty":-3.606889,"marketCap":71221461},{"date":"2023-12-22","current":-0.4466,"twenty":-12.584725,"median":-7.117764,"eighty":-3.56011,"marketCap":63883492},{"date":"2023-12-29","current":-0.525057,"twenty":-12.580983,"median":-7.097292,"eighty":-3.545216,"marketCap":75106268},{"date":"2024-01-05","current":-0.651795,"twenty":-12.554196,"median":-7.08698,"eighty":-3.493515,"marketCap":93235367},{"date":"2024-01-12","current":-0.917341,"twenty":-12.52908,"median":-7.069188,"eighty":-3.412271,"marketCap":131220146},{"date":"2024-01-19","current":-0.737796,"twenty":-12.524241,"median":-7.035777,"eighty":-3.263323,"marketCap":105537256},{"date":"2024-01-26","current":-1.324851,"twenty":-12.51857,"median":-7.023513,"eighty":-2.747451,"marketCap":189511962},{"date":"2024-02-02","current":-1.772434,"twenty":-12.509859,"median":-7.000611,"eighty":-2.585064,"marketCap":253536017},{"date":"2024-02-09","current":-1.938779,"twenty":-12.491736,"median":-6.991314,"eighty":-2.31987,"marketCap":277330659},{"date":"2024-02-16","current":-1.720809,"twenty":-12.462618,"median":-6.972037,"eighty":-2.243983,"marketCap":246151473},{"date":"2024-02-23","current":-1.399592,"twenty":-12.450225,"median":-6.949178,"eighty":-2.172992,"marketCap":200203198},{"date":"2024-03-01","current":-1.347967,"twenty":-12.414285,"median":-6.907999,"eighty":-1.977153,"marketCap":192818653},{"date":"2024-03-08","current":-1.370912,"twenty":-12.401486,"median":-6.8743,"eighty":-1.880799,"marketCap":196100673},{"date":"2024-03-15","current":-1.175886,"twenty":-12.358945,"median":-6.850352,"eighty":-1.832088,"marketCap":168203506},{"date":"2024-03-22","current":-1.174797,"twenty":-12.339673,"median":-6.835853,"eighty":-1.784285,"marketCap":167594127},{"date":"2024-03-28","current":-1.341802,"twenty":-12.313113,"median":-6.812023,"eighty":-1.720809,"marketCap":191418782},{"date":"2024-04-05","current":-1.313008,"twenty":-12.311632,"median":-6.801251,"eighty":-1.686393,"marketCap":187311083},{"date":"2024-04-12","current":-1.289973,"twenty":-12.302962,"median":-6.791354,"eighty":-1.588881,"marketCap":184024924},{"date":"2024-04-19","current":-1.16638,"twenty":-12.277396,"median":-6.697444,"eighty":-1.399592,"marketCap":166393446},{"date":"2024-04-26","current":-1.042542,"twenty":-12.223294,"median":-6.665694,"eighty":-1.382114,"marketCap":148726981},{"date":"2024-05-03","current":-0.812146,"twenty":-12.21417,"median":-6.589793,"eighty":-1.370912,"marketCap":115859140},{"date":"2024-05-10","current":-0.938864,"twenty":-12.197035,"median":-6.535968,"eighty":-1.357033,"marketCap":133936452},{"date":"2024-05-17","current":-0.922882,"twenty":-12.194874,"median":-6.505876,"eighty":-1.341802,"marketCap":129012399},{"date":"2024-05-24","current":-0.899369,"twenty":-12.179177,"median":-6.443695,"eighty":-1.324851,"marketCap":125725459},{"date":"2024-05-31","current":-0.869978,"twenty":-12.088212,"median":-6.437221,"eighty":-1.31375,"marketCap":121616784},{"date":"2024-06-07","current":-0.822952,"twenty":-12.061179,"median":-6.407834,"eighty":-1.306296,"marketCap":115042904},{"date":"2024-06-14","current":-0.852343,"twenty":-12.055847,"median":-6.386025,"eighty":-1.290353,"marketCap":119151579},{"date":"2024-06-21","current":-0.799439,"twenty":-12.037385,"median":-6.32468,"eighty":-1.28809,"marketCap":111755964},{"date":"2024-06-28","current":-0.787682,"twenty":-12.021764,"median":-6.317751,"eighty":-1.28111,"marketCap":110112494},{"date":"2024-07-05","current":-0.640727,"twenty":-12.000582,"median":-6.289626,"eighty":-1.264729,"marketCap":89569118},{"date":"2024-07-12","current":-0.740657,"twenty":-11.985072,"median":-6.236551,"eighty":-1.250908,"marketCap":103538613},{"date":"2024-07-15","current":-0.711265,"twenty":-11.982873,"median":-6.236317,"eighty":-1.24294,"marketCap":99429938},{"date":"2024-08-02","current":-0.887612,"twenty":-11.980674,"median":-6.236082,"eighty":-1.238143,"marketCap":124081989},{"date":"2024-08-09","current":-0.781804,"twenty":-11.969581,"median":-6.205324,"eighty":-1.199511,"marketCap":109290758},{"date":"2024-08-16","current":-0.858275,"twenty":-11.817433,"median":-6.189946,"eighty":-1.16638,"marketCap":117833372},{"date":"2024-08-23","current":-0.924296,"twenty":-11.792089,"median":-6.174413,"eighty":-1.118526,"marketCap":126897478},{"date":"2024-08-30","current":-0.888284,"twenty":-11.791422,"median":-6.123071,"eighty":-1.079982,"marketCap":121953420},{"date":"2024-09-06","current":-0.864276,"twenty":-11.774207,"median":-6.117646,"eighty":-1.042246,"marketCap":118657382},{"date":"2024-09-13","current":-0.918294,"twenty":-11.746525,"median":-6.097673,"eighty":-1.023256,"marketCap":126073468},{"date":"2024-09-20","current":-0.912292,"twenty":-11.737434,"median":-6.059226,"eighty":-1.003173,"marketCap":125249459},{"date":"2024-09-27","current":-0.840269,"twenty":-11.732746,"median":-6.031064,"eighty":-0.967521,"marketCap":115361344},{"date":"2024-10-04","current":-0.852273,"twenty":-11.721863,"median":-5.997732,"eighty":-0.951895,"marketCap":117009363},{"date":"2024-10-11","current":-0.840269,"twenty":-11.652742,"median":-5.948405,"eighty":-0.941944,"marketCap":115361344},{"date":"2024-10-18","current":-0.888284,"twenty":-11.621631,"median":-5.943886,"eighty":-0.924013,"marketCap":121953420},{"date":"2024-10-25","current":-0.852273,"twenty":-11.588658,"median":-5.911442,"eighty":-0.918294,"marketCap":117009363},{"date":"2024-10-31","current":-0.816261,"twenty":-11.499297,"median":-5.901417,"eighty":-0.916531,"marketCap":112065305},{"date":"2024-11-08","current":-0.92967,"twenty":-11.439414,"median":-5.89006,"eighty":-0.912292,"marketCap":109593276},{"date":"2024-11-15","current":-0.73395,"twenty":-11.435946,"median":-5.866992,"eighty":-0.903278,"marketCap":86521008},{"date":"2024-11-22","current":-0.638886,"twenty":-11.429986,"median":-5.811777,"eighty":-0.89627,"marketCap":75314477},{"date":"2024-11-29","current":-0.78987,"twenty":-11.418431,"median":-5.784713,"eighty":-0.894286,"marketCap":93113084},{"date":"2024-12-06","current":-0.690193,"twenty":-11.401272,"median":-5.743886,"eighty":-0.888284,"marketCap":81362707},{"date":"2024-12-13","current":-0.681106,"twenty":-11.388213,"median":-5.695534,"eighty":-0.884414,"marketCap":80291495},{"date":"2024-12-20","current":-0.60135,"twenty":-11.375618,"median":-5.631169,"eighty":-0.87628,"marketCap":70889545},{"date":"2024-12-27","current":-0.67104,"twenty":-11.366584,"median":-5.534139,"eighty":-0.875575,"marketCap":79104921},{"date":"2025-01-03","current":-0.680687,"twenty":-11.366584,"median":-5.50515,"eighty":-0.869978,"marketCap":80242054},{"date":"2025-01-10","current":-0.67104,"twenty":-11.36489,"median":-5.476941,"eighty":-0.863653,"marketCap":79104921},{"date":"2025-01-17","current":-0.642801,"twenty":-11.345353,"median":-5.447215,"eighty":-0.858275,"marketCap":75775922},{"date":"2025-01-24","current":-0.659437,"twenty":-11.320593,"median":-5.44142,"eighty":-0.858275,"marketCap":77737065},{"date":"2025-01-31","current":-0.62211,"twenty":-11.303257,"median":-5.420147,"eighty":-0.852343,"marketCap":73336854},{"date":"2025-02-07","current":-0.71997,"twenty":-11.293364,"median":-5.395061,"eighty":-0.852273,"marketCap":84872988},{"date":"2025-02-14","current":-0.628751,"twenty":-11.288553,"median":-5.316757,"eighty":-0.84661,"marketCap":74119663},{"date":"2025-02-21","current":-0.699,"twenty":-11.285085,"median":-5.293755,"eighty":-0.846349,"marketCap":82400960},{"date":"2025-02-28","current":-0.600861,"twenty":-11.276415,"median":-5.256736,"eighty":-0.840269,"marketCap":70831865},{"date":"2025-03-07","current":-0.591354,"twenty":-11.263085,"median":-5.126616,"eighty":-0.836632,"marketCap":69711212},{"date":"2025-03-14","current":-0.54777,"twenty":-11.245427,"median":-4.977667,"eighty":-0.828729,"marketCap":64155873},{"date":"2025-03-21","current":-0.53958,"twenty":-11.234373,"median":-4.923562,"eighty":-0.822952,"marketCap":63196718},{"date":"2025-03-28","current":-0.600083,"twenty":-11.229199,"median":-4.869457,"eighty":-0.813792,"marketCap":70282887},{"date":"2025-04-04","current":-0.473712,"twenty":-11.203586,"median":-4.814322,"eighty":-0.799439,"marketCap":55482138},{"date":"2025-04-11","current":-0.315643,"twenty":-11.163703,"median":-4.768078,"eighty":-0.793561,"marketCap":36968798},{"date":"2025-04-17","current":-0.403326,"twenty":-11.153299,"median":-4.755552,"eighty":-0.78812,"marketCap":47238368}],"updateTime":1745177668414}}}